Pediatric psoriasis and psoriatic arthritis

Dermatologic Therapy
Debra Lewkowicz, Alice B Gottlieb

Abstract

Psoriasis and psoriatic arthritis (PsA) are not uncommon among the pediatric population. Recognizing and treating these chronic disorders in children present unique challenges for the dermatologist. Paucity of clinical trials and a dearth of available treatment modalities, many of which carry significant risk or adverse effects, can make treating pediatric psoriasis and PsA a daunting task. This review attempts to define and consolidate the current state of knowledge with regards to this disease spectrum. The need for further clinical trials to investigate treatment options in the pediatric population is also discussed.

References

Jun 1, 1978·Archives of Dermatology·F BrandrupB Eriksen
Jun 1, 1977·The Journal of Investigative Dermatology·J W MelskiH L Bleich
Apr 1, 1991·Journal of the American Academy of Dermatology·N J LoweR Armstrong
Sep 1, 1991·Archives of Dermatology·B D Zelickson, S A Muller
Sep 1, 1990·Annals of the Rheumatic Diseases·M L HamiltonE D Silverman
Mar 1, 1990·Pediatric Dermatology·A NandaB Kumar
Aug 1, 1988·The Journal of Investigative Dermatology·R S Stern, R Lange
Dec 1, 1982·Journal of the American Academy of Dermatology·B S PaulJ A Parrish
Nov 1, 1994·International Journal of Dermatology·A ZvulunovA Metzker
Mar 2, 1995·The New England Journal of Medicine·M W Greaves, G D Weinstein
Nov 1, 1994·Journal of the American Academy of Dermatology·S BruceC Whitmore
Sep 1, 1994·Pediatric Dermatology·B KumarI Kaur
Jun 1, 1994·Pediatric Dermatology·A S al-Fouzan, A Nanda
May 1, 1994·Baillière's Clinical Rheumatology·B M Ansell
Apr 1, 1994·Clinical and Experimental Immunology·P EttehadiR D Camp
Jan 1, 1994·The British Journal of Dermatology·E L Speight, P M Farr
Sep 1, 1993·Journal of the American Academy of Dermatology·D L DuffyN G Martin
Sep 1, 1996·Pediatric Dermatology·Y K TayW L Weston
Sep 1, 1996·Current Opinion in Rheumatology·R Häfner, H Michels
Jan 1, 1996·Dermatology : International Journal for Clinical and Investigative Dermatology·H MaierH Hönigsmann
Feb 1, 1997·Journal of the American Academy of Dermatology·A P OranjeM Axelsen
Jun 1, 1997·The Journal of Investigative Dermatology·R S SternUNKNOWN PUVA Follow-up Study
Aug 1, 1997·Journal of the American Academy of Dermatology·G D Weinstein
Aug 15, 1998·Dermatologic Clinics·R Howard, A Tsuchiya
Aug 15, 1998·Dermatologic Clinics·D I Czyzewski, M Lopez
Oct 20, 1998·Journal of the American Academy of Dermatology·M G LebwohlJ Sefton
Oct 20, 1998·Journal of the American Academy of Dermatology·J Y Koo
Dec 16, 1998·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·M R LearyS R Feldman
Jun 12, 1999·Arthritis and Rheumatism·P RahmanA Petronis
Jul 20, 1999·Journal of the American Academy of Dermatology·J Koo, M Lebwohl
Sep 16, 1999·International Journal of Dermatology·T J FranzW S Harkonen
Mar 25, 2000·Clinical and Experimental Dermatology·A NandaI Al-Muzairai
Apr 18, 2000·Journal of the American Academy of Dermatology·R A HerbstJ Weiss
Jul 8, 2000·Pediatric Dermatology·S P Raychaudhuri, J Gross
Jul 5, 2001·Pediatric Dermatology·A MorrisK Williams

❮ Previous
Next ❯

Citations

Jul 3, 2008·Skeletal Radiology·Edward Y LeePaul K Kleinman
May 17, 2013·American Journal of Clinical Dermatology·Kara N Shah
Jan 18, 2008·The New England Journal of Medicine·Amy S PallerUNKNOWN Etanercept Pediatric Psoriasis Study Group
Jun 5, 2007·Pediatric Dermatology·Laura DiluvioSergio Chimenti
Dec 25, 2010·Pediatric Dermatology·Kimberly R KortuemSara A Farmer
Jul 9, 2011·Pediatric Dermatology·Agneta GånemoÅke Svensson
May 3, 2014·BMJ Case Reports·Tom Edward Ngo LoMichael L Tee
Nov 26, 2009·Journal of the American Academy of Dermatology·David M RosmarinUNKNOWN National Psoriasis Foundation
Jun 19, 2009·Journal of the American Academy of Dermatology·Bruce StroberMelodie Young
Mar 29, 2005·Pediatric Annals·Robert L Buka, Bari B Cunningham
Jan 1, 2008·Advances in Dermatology·Kelly M Cordoro
Jun 15, 2005·Dermatologic Therapy·Bernice R Krafchik
Feb 19, 2009·Dermatologic Therapy·Smita V Sukhatme, Alice B Gottlieb
Aug 27, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Mona StåhleWolfram Sterry
Apr 5, 2014·International Journal of Dermatology·Aikaterini-Evangelia MoustouChristina Antoniou
Oct 6, 2006·Expert Opinion on Pharmacotherapy·Uwe WollinaMohamed Badawy Abdel-Naser
Dec 17, 2017·The Journal of Rheumatology·Aaida SamadUNKNOWN CARRA Legacy Registry Investigators
May 12, 2007·American Journal of Clinical Dermatology·Uwe Wollina
Apr 21, 2009·Anais Brasileiros De Dermatologia·Ricardo RomitiMaria Denise Fonseca Takahashi
Jul 16, 2008·Current Opinion in Pediatrics·Leah Belazarian
May 1, 2020·Paediatric Drugs·Quoc-Bao D NguyenAdelaide A Hebert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.